Home LiteratureArticle Details
PMID: 6420570 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III.

Journal of medicinal chemistry ·Vol. 27 ·No. 2 ·1984-02-00 ·Pages 181-5

Wright GE, Gambino JJ

Abstract

Quantitative structure-activity relationships (QSAR) of a series of 6-anilinouracil derivatives were developed for their inhibitory activity against the wild-type DNA polymerase III (pol III) and a mutant enzyme, pol III/azp-12, derived from Bacillus subtilis. Interaction between inhibitors and both enzymes appears to result solely from hydrophobic binding. Comparison of the substituent contributions indicates increased hydrophobic character and a minor change of shape of the inhibitor binding site of the mutant enzyme. Because the two enzymes have identical Km values for substrates, the inhibitor binding site is thought to be distinct from the enzyme active site.

MeSH Terms
Bacillus subtilis/enzymology Binding Sites Chemical Phenomena Chemistry, Physical DNA Polymerase III/antagonists & inhibitors,genetics Mathematics Mutation Nucleic Acid Synthesis Inhibitors Structure-Activity Relationship Uracil/analogs & derivatives,pharmacology
Chemicals
Nucleic Acid Synthesis Inhibitors Uracil DNA Polymerase III
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wright G E
Gambino J J
Article Info
Journal
Journal of medicinal chemistry
Abbr.
J Med Chem
ISSN
0022-2623
Published
1984-02-00
Pages
181-5
Language
English
Region
United States
NLM ID
9716531
Subset
IM
Grants
NIGMS NIH HHS · GM 21747 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]